Skip to main content
Neural Therapeutics Inc. logo

Neural Therapeutics Inc. — Investor Relations & Filings

Ticker · NURL ISIN · CA64134N2032 LEI · 894500KBZO3KS9715774 CSE Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country CA Canada
Listing CSE NURL

About Neural Therapeutics Inc.

https://neuraltherapeutics.ca/

Neural Therapeutics Inc. is an ethnobotanical drug discovery and development company operating in the pharmaceutical and nutraceutical sectors. It focuses on developing therapeutic drugs for mental illnesses, including those related to substance abuse, and over-the-counter dietary supplements. The company integrates modern scientific research with traditional indigenous knowledge regarding psychoactive plants and whole plant extracts. Initial R&D centers on the San Pedro cactus (Echinopsis pachanoi), which contains mescaline. Neural Therapeutics pursues a dual-path strategy to develop both pharmaceutical and nutraceutical products, aiming for whole plant utilization and zero waste.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 10% confidence The document is a news release/press announcement about Hanf.com store openings and refurbishments, not an actual financial report, management discussion, earnings release, or regulatory certification. It does not fit any specific category like earnings, M&A, board changes, or capital changes. As a general corporate announcement, it falls under the fallback ‘Regulatory Filings’ category (RNS).
2026-05-19 English
News release - English.pdf
Regulatory Filings
2026-05-01 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Availability of Proxy Materials for the Annual General and Special Meeting, providing shareholders with instructions on accessing and requesting proxy materials, summarizing the resolutions to be voted on, and outlining voting procedures. This aligns with the Proxy Solicitation & Information Statement category rather than an actual annual report or earnings release.
2026-04-17 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the Annual General and Special Meeting of shareholders, soliciting votes on various resolutions (director elections, auditor appointment, share consolidation, etc.). It is part of the proxy solicitation materials sent to shareholders to request votes at the AGM, fitting the Proxy Solicitation & Information Statement category.
2026-04-17 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of the annual and special meeting of shareholders, including the meeting agenda, record date, proxy voting instructions, and reference to an accompanying Circular used to solicit shareholder votes. This aligns closely with a proxy solicitation and information statement, rather than an actual financial report or earnings release.
2026-04-17 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a combined Notice of Annual and Special Meeting of Shareholders and Management Proxy Circular for Neural Therapeutics Inc. It provides detailed background on proposed resolutions, director elections, name change, share consolidation, equity transactions, and voting instructions. This matches the definition of Proxy Solicitation & Information Statement (materials sent to shareholders to provide information and request votes for meetings).
2026-04-17 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.